- Home
- ZENA vs HLVX Comparison
ZENA vs HLVX Comparison
Compare ZENA & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENA
- HLVX
- Stock Information
- Founded
- ZENA 2017
- HLVX 2020
- Country
- ZENA Canada
- HLVX United States
- Employees
- ZENA N/A
- HLVX N/A
- Industry
- ZENA
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- ZENA
- HLVX Health Care
- Exchange
- ZENA NYSE
- HLVX Nasdaq
- Market Cap
- ZENA 82.4M
- HLVX 83.7M
- IPO Year
- ZENA N/A
- HLVX 2022
- Fundamental
- Price
- ZENA $2.12
- HLVX $1.36
- Analyst Decision
- ZENA
- HLVX Hold
- Analyst Count
- ZENA 0
- HLVX 5
- Target Price
- ZENA N/A
- HLVX $2.33
- AVG Volume (30 Days)
- ZENA 610.9K
- HLVX 157.5K
- Earning Date
- ZENA 01-01-0001
- HLVX 03-28-2025
- Dividend Yield
- ZENA N/A
- HLVX N/A
- EPS Growth
- ZENA N/A
- HLVX N/A
- EPS
- ZENA N/A
- HLVX N/A
- Revenue
- ZENA $1,364,714.00
- HLVX N/A
- Revenue This Year
- ZENA N/A
- HLVX N/A
- Revenue Next Year
- ZENA N/A
- HLVX N/A
- P/E Ratio
- ZENA N/A
- HLVX N/A
- Revenue Growth
- ZENA 7.43
- HLVX N/A
- 52 Week Low
- ZENA $1.41
- HLVX $1.37
- 52 Week High
- ZENA $12.43
- HLVX $16.31
- Technical
- Relative Strength Index (RSI)
- ZENA N/A
- HLVX 30.91
- Support Level
- ZENA N/A
- HLVX $1.37
- Resistance Level
- ZENA N/A
- HLVX $1.54
- Average True Range (ATR)
- ZENA 0.00
- HLVX 0.08
- MACD
- ZENA 0.00
- HLVX -0.02
- Stochastic Oscillator
- ZENA 0.00
- HLVX 19.28
About ZENA ZENATECH INC
ZenaTech Inc is a enterprise software technology company that specializes in mission-critical cloud-based applications integrated with smart hardware to deliver innovative solutions across diverse industries. The Company operates in software development technology, sales, and distribution. The Company is also developing a drone manufacturing, sales, and distribution business. The company operates in two segments which is software development technology, sales, and distribution, as well as drone manufacturing, sales, and distribution.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.